Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alteon (ALT) -- Ignore unavailable to you. Want to Upgrade?

To: Bill Tomko who wrote (225)	3/12/1998 3:53:00 PM
From: Rudy Saucillo	Read Replies (1) \| Respond to of 318

<<I haven't spoken to the company in a couple of months so you may be correct; however may understanding was the action I completed this summer.>> Yeah, they're still on schedule to complete the trial in the August timeframe. Given the size of the trial and number of sites, compiling and evaluating the data in coordination with GNE will take a fair amount of time. ALTN plans to review the data with the FDA prior to public release. This is something of an unpredictable variable in the schedule, but without a doubt, a very prudent move. Hence ALTN's 4Q98 estimate for public release of the data. I'll be sure and check out DTL! Rudy